Mirikizumab

含有 Mirikizumab 的品牌、食物注意事项以及最重要的药物相互作用。

品牌

MISUVYA 100 MG/1 ML ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR KALEM, 2 ADET条形码：8699673955049
MISUVYA 300 MG/15 ML INFUZYONLUK COZELTI HAZIRLAMAK ICIN KONSANTRE条形码：8699673765235

食物注意事项

该活性成分暂无已收录的食物注意事项。

最重要的相互作用

前 10 项，共 50 项

2-Methoxyethanol中等
当 2-Methoxyethanol 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Mirikizumab.
9-(N-methyl-L-isoleucine)-cyclosporin A中等
当 9-(N-methyl-L-isoleucine)-cyclosporin A 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 9-(N-methyl-L-isoleucine)-cyclosporin A is combined with Mirikizumab.
Abatacept中等
当 Abatacept 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Abatacept is combined with Mirikizumab.
Abetimus中等
当 Abetimus 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Abetimus is combined with Mirikizumab.
Acteoside中等
当 Acteoside 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Acteoside is combined with Mirikizumab.
Adalimumab中等
当 Adalimumab 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Adalimumab is combined with Mirikizumab.
Adenovirus type 7 vaccine live中等
当 Mirikizumab 与 Adenovirus type 7 vaccine live 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Mirikizumab is combined with Adenovirus type 7 vaccine live.
Afelimomab中等
当 Afelimomab 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Afelimomab is combined with Mirikizumab.
Aldesleukin中等
当 Aldesleukin 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mirikizumab.
Aldosterone中等
当 Aldosterone 与 Mirikizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Aldosterone is combined with Mirikizumab.